Advanced search
Publication Cover
Journal of Drug Targeting Volume 28, 2020 - Issue 9
Submit an article Journal homepage
130
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Coptis inhibited epithelial–mesenchymal transition and fibrogenesis of diabetic nephropathy through lncRNA CLYBL-AS2-miR-204-5p-SNAI1 axis

Shengyu CaiThe 2nd Clinical Medical College (Shenzhen People’s Hospital) of Jinan University, Shenzhen, PR China; ;Integrated Chinese and Western Medicine, Postdoctoral Research Station, Jinan University, Guangzhou, PR China; View further author information
,
Juan LiuDepartment of Hematology & Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, PR China; View further author information
,
Qingyu MaFormula-Pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, PR China; View further author information
,
Yuxiao BaoLonggang Traditional Chinese Medicine Hospital, Beijing University of Chinese Medicine Shenzhen Hospital, Shenzhen, PR China; View further author information
,
Jiaxu ChenFormula-Pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, PR China; ;School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, PR ChinaCorrespondence[email protected]
View further author information
&
Yousheng LiThe 2nd Clinical Medical College (Shenzhen People’s Hospital) of Jinan University, Shenzhen, PR China; Correspondence[email protected]
View further author information
Pages 939-948 | Received 27 Nov 2019, Accepted 19 Apr 2020, Published online: 13 May 2020

References

  • Jourdan T, Park JK, Varga ZV, et al. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy. Diabetes Obes Metab. 2018;20(3):698–708.
  • Gross JL, de Azevedo MJ, Silveiro SP, et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164–176.
  • Li WL, Zheng HC, Bukuru J, et al. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 2004;92(1):1–21.
  • Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J. 1982;285(6343):685–688.
  • Sun GD, Li CY, Cui WP, et al. Review of herbal traditional Chinese medicine for the treatment of diabetic nephropathy. J Diabet Res. 2016;2016:1–18.
  • Simonson MS. Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int. 2007;71(9):846–854.
  • Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol. 2010;21(11):1819–1834.
  • Wang JY, Gao YB, Zhang N, et al. miR-21 overexpression enhances TGF-beta1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Mol Cell Endocrinol. 2014;392(1–2):163–172.
  • Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–159.
  • Sampaio E, Barbosa DS, Mazzuco TL, et al. Impaired antioxidant action of high density lipoprotein in patients with type 1 diabetes with normoalbuminuria and microalbuminuria. Diabet Res Clin Pract. 2013;99(3):321–326.
  • Wang M, Wang S, Yao D, et al. A novel long non-coding RNA CYP4B1-PS1-001 regulates proliferation and fibrosis in diabetic nephropathy. Mol Cell Endocrinol. 2016;426:136–145.
  • Liu Z, Luo H, Zhang L, et al. Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice. Circ Res. 2012;111(10):1261–1273.
  • Nishimura M. Breeding of mice strains for diabetes mellitus. Exp Anim. 1969;18(4):147–157.
  • Tomino Y. Lessons from the KK-Ay mouse, a spontaneous animal model for the treatment of human type 2 diabetic nephropathy. Nephro Urol Mon. 2012;4(3):524–529.
  • Long J, Badal SS, Ye Z, et al. Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy. J Clin Invest. 2016;126(11):4205–4218.
  • He F, Peng F, Xia X, et al. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia. 2014;57(8):1726–1736.
  • Li X, Zeng L, Cao C, et al. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy. Exp Cell Res. 2017;350(2):327–335.
  • Gao J, Wang W, Wang F, et al. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy. Biomed Pharmacother Biomed Pharmacother. 2018;106:543–552.
  • Burns WC, Thomas MC. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. Expert Rev Mol Med. 2010;12:e17.
  • Xiong J, Liu Y, Jiang L, et al. High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma. Jpn J Clin Oncol. 2016;46(4):378–384.
  • Xie H, Xue JD, Chao F, et al. Long non-coding RNA-H19 antagonism protects against renal fibrosis. Oncotarget. 2016;7(32):51473–51481.
  • Guo W, Qiu Z, Wang Z, et al. MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. Hepatology. 2015;62(4):1132–1144.
  • Tong XL, Dong L, Chen L, et al. Treatment of diabetes using traditional Chinese medicine: past, present and future. Am J Chin Med. 2012;40(05):877–886.
  • Alkhalaf A, Zurbig P, Bakker SJ, et al. Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy. PLoS One. 2010;5(10):e13421.
  • Vedralova M, Kotrbova-Kozak A, Zeleznikova V, et al. Polymorphisms in the vitamin D receptor gene and parathyroid hormone gene in the development and progression of diabetes mellitus and its chronic complications, diabetic nephropathy and non-diabetic renal disease. Kidney Blood Press Res. 2012;36(1):1–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.